CRP and rheumatoid arthritis: Fortunately, physicians appear to be aware of the need to monitor CVD risk in patients with active RA: a study of 14,503 patients in world-wide data from the SUrvey of cardiovascular disease Risk Factor management in Rheumatoid Arthritis (SURF-RA) database demonstrated that positivity for rheumatoid factor and anticitrullinated protein antibodies, longer disease duration and higher disease activity (measured by Disease Activity Score 28 joint count-C reactive protein (CRP)) was associated with a higher likelihood of lipid and blood pressure assessments [54].